JP2014530631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530631A5 JP2014530631A5 JP2014537601A JP2014537601A JP2014530631A5 JP 2014530631 A5 JP2014530631 A5 JP 2014530631A5 JP 2014537601 A JP2014537601 A JP 2014537601A JP 2014537601 A JP2014537601 A JP 2014537601A JP 2014530631 A5 JP2014530631 A5 JP 2014530631A5
- Authority
- JP
- Japan
- Prior art keywords
- sucrose solution
- arsine
- dihydroquercetin
- glycyrrhizin
- sid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 claims description 6
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 claims description 4
- 239000004378 Glycyrrhizin Substances 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- -1 dihydrochalcone glucoside Chemical class 0.000 claims description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 4
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims description 2
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 claims description 2
- XJIPREFALCDWRQ-UYQGGQRHSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-[(3r,6r)-2-hydroxy-6-[(3s,8s,9r,10r,11r,13r,14s,17r)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1h-cyclop Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJIPREFALCDWRQ-UYQGGQRHSA-N 0.000 claims description 2
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 2
- QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 claims description 2
- NNXQSUSEFPRCRS-YCKMUKMSSA-N 3-[(3S,3aR,4R,5aR,6S,7S,9aR,9bR)-3-[(E,2S)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-prop-1-en-2-yl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1[C@@H]2[C@@H]([C@@](C)(O)C\C=C\C(C)(C)O)CC[C@@]2(C)[C@]2(C)CC[C@@H](C(C)=C)[C@](C)(CCC(O)=O)[C@H]2C1 NNXQSUSEFPRCRS-YCKMUKMSSA-N 0.000 claims description 2
- GLLUYNRFPAMGQR-UHFFFAOYSA-N Glycyphyllin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-UHFFFAOYSA-N 0.000 claims description 2
- QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 claims description 2
- OFFJUHSISSNBNT-UHFFFAOYSA-N Polypodoside A Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O OFFJUHSISSNBNT-UHFFFAOYSA-N 0.000 claims description 2
- XSDXQNVJNSCZNC-UHFFFAOYSA-N [5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl] acetate Chemical compound C1=CC(OC)=CC=C1C1C(OC(C)=O)C(=O)C2=C(O)C=C(O)C=C2O1 XSDXQNVJNSCZNC-UHFFFAOYSA-N 0.000 claims description 2
- 229930193947 albiziasaponin Natural products 0.000 claims description 2
- JOKKBOSZTVHKSH-UHFFFAOYSA-N baiyunoside Natural products CC12CCC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C(C)(C)C1CCC(C)=C2CCC=1C=COC=1 JOKKBOSZTVHKSH-UHFFFAOYSA-N 0.000 claims description 2
- 108010010165 curculin Proteins 0.000 claims description 2
- XCGZWJIXHMSSQC-UHFFFAOYSA-N dihydroquercetin Natural products OC1=CC2OC(=C(O)C(=O)C2C(O)=C1)c1ccc(O)c(O)c1 XCGZWJIXHMSSQC-UHFFFAOYSA-N 0.000 claims description 2
- GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 claims description 2
- 229930191869 mogroside IV Natural products 0.000 claims description 2
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 claims description 2
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 claims description 2
- OHLBTNZSOHMDGY-JNMXELLOSA-N mukurozioside IIb Natural products O(C/C(=C\CC/C(=C\CC/C(=C\CO[C@H]1[C@H](O[C@@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](O)[C@@H](CO)O1)/C)/C)/C)[C@H]1[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](O)[C@@H](CO)O1 OHLBTNZSOHMDGY-JNMXELLOSA-N 0.000 claims description 2
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical compound C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 claims description 2
- 150000003085 polypodoside A derivatives Polymers 0.000 claims description 2
- DMRIOWKDQLGGAP-UHFFFAOYSA-N polypodoside B Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1O DMRIOWKDQLGGAP-UHFFFAOYSA-N 0.000 claims description 2
- DMRIOWKDQLGGAP-FPYDNAILSA-N polypodoside B group Chemical group [C@@H]12CC[C@H]([C@H](C)[C@H]3CC[C@H](C)[C@@H](OC4OC(C)C(O)C(O)C4O)O3)[C@@]1(C)CC[C@H]1C2=CC(=O)[C@H]2C[C@H](CC[C@]12C)OC1OC(CO)C(O)C(O)C1O DMRIOWKDQLGGAP-FPYDNAILSA-N 0.000 claims description 2
- NNXQSUSEFPRCRS-UHFFFAOYSA-N pterocaryoside A Natural products OC1C(O)C(O)C(C)OC1OC1C2C(C(C)(O)CC=CC(C)(C)O)CCC2(C)C2(C)CCC(C(C)=C)C(C)(CCC(O)=O)C2C1 NNXQSUSEFPRCRS-UHFFFAOYSA-N 0.000 claims description 2
- SODWWCZKQRRZTG-UHFFFAOYSA-N pterocaryoside B Natural products OC(=O)CCC1(C)C(C(=C)C)CCC(C2(CCC(C22)C(C)(O)CC=CC(C)(C)O)C)(C)C1CC2OC1OCC(O)C(O)C1O SODWWCZKQRRZTG-UHFFFAOYSA-N 0.000 claims description 2
- XJIPREFALCDWRQ-UHFFFAOYSA-N siamenoside I Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)OC2C(C(O)C(O)C(CO)O2)O)OC1COC1OC(CO)C(O)C(O)C1O XJIPREFALCDWRQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000892 thaumatin Substances 0.000 claims description 2
- 235000010436 thaumatin Nutrition 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 4
- 229930006000 Sucrose Natural products 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 239000005720 sucrose Substances 0.000 claims 4
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims 1
- 239000001183 FEMA 4495 Substances 0.000 claims 1
- 239000001689 FEMA 4674 Substances 0.000 claims 1
- CWBZAESOUBENAP-QVNVHUMTSA-N Naringin dihydrochalcone Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C(O)C(C(=O)CCC=3C=CC(O)=CC=3)=C(O)C=2)O[C@H](CO)[C@@H](O)[C@@H]1O CWBZAESOUBENAP-QVNVHUMTSA-N 0.000 claims 1
- 241001092459 Rubus Species 0.000 claims 1
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims 1
- 229930182647 Trilobatin Natural products 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 claims 1
- 229930182478 glucoside Natural products 0.000 claims 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 claims 1
- 229930183085 periandrin Natural products 0.000 claims 1
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 claims 1
- 239000003623 enhancer Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550495P | 2011-10-24 | 2011-10-24 | |
| US61/550,495 | 2011-10-24 | ||
| PCT/EP2012/071088 WO2013060746A1 (en) | 2011-10-24 | 2012-10-24 | Compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530631A JP2014530631A (ja) | 2014-11-20 |
| JP2014530631A5 true JP2014530631A5 (https=) | 2015-12-17 |
| JP6353364B2 JP6353364B2 (ja) | 2018-07-04 |
Family
ID=47115891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537601A Active JP6353364B2 (ja) | 2011-10-24 | 2012-10-24 | 組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140370177A1 (https=) |
| EP (1) | EP2770843B1 (https=) |
| JP (1) | JP6353364B2 (https=) |
| CN (1) | CN104039166B (https=) |
| BR (1) | BR112014009376B1 (https=) |
| IN (1) | IN2014CN02970A (https=) |
| MX (1) | MX354411B (https=) |
| SG (1) | SG11201401335QA (https=) |
| WO (1) | WO2013060746A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201418893D0 (en) | 2014-10-23 | 2014-12-10 | Univ Hull | Monolithic body |
| GB201418897D0 (en) | 2014-10-23 | 2014-12-10 | Univ Hull | Methods and apparatus for the analysis of compounds |
| GB201418899D0 (en) | 2014-10-23 | 2014-12-10 | Univ Hull | System for radiopharmaceutical production |
| CN107532189B (zh) * | 2015-03-10 | 2021-12-17 | 格罗宁根大学 | 甜菊醇糖苷的酶修饰的方法、由此可获得的修饰的甜菊醇糖苷及其作为甜味剂的用途 |
| PL3504983T3 (pl) * | 2016-12-30 | 2024-02-05 | Red Bull Gmbh | Kompozycje słodzące |
| WO2018122383A1 (en) * | 2016-12-30 | 2018-07-05 | Red Bull Gmbh | Sweetening compositions |
| US11076619B2 (en) | 2016-12-30 | 2021-08-03 | Red Bull Gmbh | Sweetening compositions |
| RU2762719C2 (ru) * | 2017-06-02 | 2021-12-22 | Живодан Са | Композиция, модифицирующая сладость |
| JP7003249B2 (ja) | 2017-10-23 | 2022-01-20 | シムライズ アーゲー | 芳香組成物 |
| US20200221722A1 (en) * | 2019-01-15 | 2020-07-16 | Kween Foods LLC | Granola butter product and process of making a granola butter product |
| US20220273012A1 (en) * | 2019-09-05 | 2022-09-01 | Firmenich Sa | Flavanone derivatives and their use as sweetness enhancers |
| CN114513968A (zh) * | 2019-12-23 | 2022-05-17 | 弗门尼舍有限公司 | 三萜葡萄糖醛酸苷及其作为风味改良剂的用途 |
| CA3179775A1 (en) | 2020-04-20 | 2021-10-28 | Givaudan Sa | Compositions |
| GB202007984D0 (en) | 2020-05-28 | 2020-07-15 | Givaudan Sa | Compositions |
| EP4716465A1 (en) | 2023-05-22 | 2026-04-01 | Givaudan SA | Dried cocoa pulp composition, consumables and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293305B2 (en) * | 2005-10-11 | 2012-10-23 | Purecircle Sdn Bhd | Process for manufacturing a sweetener and use thereof |
| WO2007121604A2 (en) * | 2006-04-20 | 2007-11-01 | Givaudan Sa | Method relating to sweetness enhancement |
| US20100092638A1 (en) | 2006-10-24 | 2010-04-15 | Chad Allen Hansen | Consumables |
| US9101161B2 (en) * | 2006-11-02 | 2015-08-11 | The Coca-Cola Company | High-potency sweetener composition with phytoestrogen and compositions sweetened therewith |
| MY155722A (en) * | 2007-12-03 | 2015-11-30 | Dsm Ip Assets Bv | Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof |
| CN101220062A (zh) * | 2008-01-23 | 2008-07-16 | 石任兵 | 一种同时制备甜菊苷和莱鲍迪苷a的方法 |
| CA2773134A1 (en) * | 2009-09-04 | 2011-03-10 | Redpoint Bio Corporation | Sweetness enhancers including rebaudioside a or d |
-
2012
- 2012-10-24 CN CN201280052169.0A patent/CN104039166B/zh active Active
- 2012-10-24 IN IN2970CHN2014 patent/IN2014CN02970A/en unknown
- 2012-10-24 JP JP2014537601A patent/JP6353364B2/ja active Active
- 2012-10-24 US US14/352,223 patent/US20140370177A1/en active Pending
- 2012-10-24 SG SG11201401335QA patent/SG11201401335QA/en unknown
- 2012-10-24 MX MX2014004694A patent/MX354411B/es active IP Right Grant
- 2012-10-24 EP EP12780165.2A patent/EP2770843B1/en active Active
- 2012-10-24 WO PCT/EP2012/071088 patent/WO2013060746A1/en not_active Ceased
- 2012-10-24 BR BR112014009376-8A patent/BR112014009376B1/pt active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530631A5 (https=) | ||
| AR097213A1 (es) | Composiciones edulcorantes | |
| JP2009531457A5 (https=) | ||
| BRPI0715563B8 (pt) | ventilador mecânico controlável | |
| BR112014009376A2 (pt) | composições | |
| BR112013011882A2 (pt) | fórmula nutricional adaptada à idade com densidade calórica particularmente adaptada para bebês e crianças | |
| BR112013003216A2 (pt) | composições sintéticas de ácido biliar e métodos | |
| EP2898923A3 (en) | Isoflavones for regulating sirtuin gene expression | |
| BR112015022385A2 (pt) | droga para uma doença respiratória | |
| AU2010323104A8 (en) | Sialochimeric compounds | |
| TR200900881A2 (tr) | Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler | |
| BR112012026373A2 (pt) | derivados de ditiinopiridazinodiona | |
| Forbes et al. | COMPASS collaborative research Strand 3: Research into practice: implementing a complex psychoeducational intervention to promote early presentation in older women with breast cancer | |
| Chan | Juniors needed support over MMC/MTAS | |
| Koedam-Visser et al. | Questionnaire surveys of end of life experiences in three Dutch hospices | |
| TH106485A (th) | วิธีเพื่อป้องกันการใช้คอร์ติโคสเตียรอยด์ | |
| Cantoni et al. | Abandoning Care in Laminar Air Flow (LAF) Units and Routine High Dose Intravenous Immunoglobulines (IVIG) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Does Not Increase Mortality and Rate of Infections. | |
| Schiffrin | SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS | |
| Jones et al. | A programme of care in palliative day care | |
| Deutsch | Speaker and specialist grant program in the Ukraine. | |
| TH108410S (th) | พัดลมระบายอากาศ | |
| TH40015S1 (th) | พัดลมระบายอากาศ | |
| OSHIRO | Production, circulation, and consumption of the" regional culture" Reflections from cultural geography | |
| Råberg | Högskolan i Halmstads miljöarbete-syndliggörande för studenterna | |
| Tauseef et al. | TRPC6 Channel Mediated Calcium Entry Requires RhoA and Myosin Light Chain Kinase To Increase Lung Vascular Permeability. |